The Oncology Institute, Inc.TOIIWNASDAQ
Loading
Operating Expenses Over TimeContracting
Percentile Rank67
3Y CAGR+9.6%
5Y CAGR+28.5%
Year-over-Year Change
Expenses from normal business operations (SG&A, R&D, etc.)
3Y CAGR
+9.6%/yr
Annual compound
5Y CAGR
+28.5%/yr
Recent deceleration
Percentile
P67
Within normal range
vs 5Y Ago
3.5x
Strong expansion
Streak
1 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| 2024 | $114.11M | -16.5% |
| 2023 | $136.59M | +1.9% |
| 2022 | $134.04M | +54.6% |
| 2021 | $86.71M | +92.4% |
| 2020 | $45.07M | +38.3% |
| 2019 | $32.59M | +51.6% |
| 2018 | $21.49M | - |